Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"

NCT04403100 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1968

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Coronavirus Infection
Virus Disease
Acute Respiratory Infection
SARS-CoV Infection

Interventions

DRUG: Hydroxychloroquine Sulfate Tablets
DRUG: Lopinavir/ Ritonavir Oral Tablet
DRUG: Hydroxychloroquine Sulfate Tablets plus Lopinavir/ Ritonavir Oral Tablets
DRUG: Placebo

Sponsor

Cardresearch

Collaborators

[object Object]
[object Object]